Now announcing the foundation of the Institute for Cruelty-Free Biotechnology!
Dedicated to spreading the good news according to Former NIH Director Elias Zerhouni:
The Beginning of the End of Animal Testing is Now In Sight!
-Meant to be a meeting space with a benevolent purpose: so those who love animals can come together, and, in conjunction with biotechnology and drug development innovators, put into practice the FDA's Five Year Plan AND END ANIMAL TESTING FOREVER!!!
Hi,
I am looking for funding for a project I have in mind. I would like to approach biotech companies to explain to them that the federal government, and past-NIH director Elias Zerhouni, have announced 'the beginning of the end of animal testing.' Please see my web-site, www.crueltyfreebiotech.blogspot.com. To this end, the government has announced a 5-year plan to bring non-animal methods into use.
I would approach biotech companies and organizations, explain to them the alternatives to animal testing, what those alternatives are, when they are cost-effective, why they are efficient, and why they should use them.
Could I talk to someone there about what sort of funding might be available, and how much is appropriate to ask for?
I would do this through speaking engagements and offering workshops, which the companies would then pay for, but I need start-up funding. I have a web-site,
www.crueltyfreebiotech.blogspot.com, and could promote it through a newsletter.
I have a law degree, a decade of experience writing about biotech, and know lots of biotech companies.
Thank you!
John Otrompke
718-755-6069
John_Otrompke@yahoo.com
John J. Otrompke, JD
Brooklyn, New York
John_Otrompke@yahoo.com
718-755-6069
Employment:
Lecturer
New York College of Podiatric Medicine
December 2009
Informed consent and medical malpractice law
Contact: Dr. Anthony Iorio, DPM, 212-410-8163
Lecturer
Palmer Clinic College of Chiropractic Medicine
November 2008
Physician contracting and government regulations
contact: Dr. Shayan Sheybani, 563-884-5811
Lecturer
Wayne State University
April 2004
Intellectual property, tehnology transfer and government regulations
contact: Judy Johncox, 313-577-0300
Selected Publications:
Navigating Your Way Through the Fraud and Abuse,
Legislation, MEDICAL LABORATORY OBSERVER, November 2000.
http://www.mlo-online.com/articles/mlo1100fraud.htm
Navigating US Conflict-of-interest Rules When Commercializing Research, NATURE, 2003
http://www.nature.com/nbt/journal/v22/n7/pdf/nbt0704-921.pdf
Federal Court Firmly Rejects FDA Prohibitions, Affirms Constitutional Right to Access Experimental Lifesaving Drugs, LIFE EXTENSION FOUNDATION, November 2006
http://www.lef.org/magazine/mag2006/sep2006_report_fda_01.htm
Patent Pending: Biotech Awaits Answers on New Trends, BIOTECHNOLOGY HEALTHCARE, August 2007
Note, United States v. Nepa, DEPAUL ENVIRONMENTAL LAW
DIGEST, vol. 7, no. 2, Spring 1997, at 21.
Note, National Association of Home Builders, et al., v
Babbitt, et al., DEPAUL ENVIRONMENTAL LAW DIGEST, vol. 8,
No. 2, Spring 1998, at 20.
Education:
Juris Doctor, DePaul University College of Law, 2000
Certificate in Health Law, DePaul University College of Law
Coursework: pretrial criminal procedure, 4th and 5th Amendment, motions in limine, advanced criminal procedure criminal appellate advocacy, white collar health care crimes and international criminal law under the Rome Statute of the International Criminal Court (ICC) of the United Nations
Healthcare reimbursement, health policy, healthcare contracts, the federal Self-Referral Prohibition and Anti-Kickback Statute, managed care, medical malpractice, hospital law, antitrust law, tax issues in the 501(c)(3) setting, living wills, healthcare powers of attorney, constitutional issues in the healthcare setting
Bachelor of the Arts, Columbia College, 1996
Coursework: Journalism; creative writing; history
John J. Otrompke, JD, is not engaged in the practice of law
Sunday, April 4, 2010
Subscribe to:
Posts (Atom)